PeptideDB

3-Deazauridine (NSC 126849) 23205-42-7

3-Deazauridine (NSC 126849) 23205-42-7

CAS No.: 23205-42-7

3-Deazauridine (NSC 126849) is a uridine analog. 3-Deazauridine inhibits the biosynthesis of cytidine-5'-triphosphate by
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

3-Deazauridine (NSC 126849) is a uridine analog. 3-Deazauridine inhibits the biosynthesis of cytidine-5'-triphosphate by competitively inhibiting cytidine triphosphate synthetase. 3-Deazauridine acts synergistically with several antineoplastic/anticancer agents and works as a biological response modifier.

Physicochemical Properties


Molecular Formula C10H13NO6
Molecular Weight 243.21
Exact Mass 243.074
CAS # 23205-42-7
PubChem CID 54684286
Appearance Off-white to light yellow solid powder
Density 1.718g/cm3
Boiling Point 528ºC at 760mmHg
Melting Point 233-235ºC
Flash Point 273.1ºC
Vapour Pressure 0mmHg at 25°C
Index of Refraction 1.706
LogP -1.8
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 2
Heavy Atom Count 17
Complexity 379
Defined Atom Stereocenter Count 4
SMILES

C1=CN(C(=O)C=C1O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O

InChi Key CBOKZNLSFMZJJA-PEBGCTIMSA-N
InChi Code

InChI=1S/C10H13NO6/c12-4-6-8(15)9(16)10(17-6)11-2-1-5(13)3-7(11)14/h1-3,6,8-10,12-13,15-16H,4H2/t6-,8-,9-,10-/m1/s1
Chemical Name

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxypyridin-2-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Cytidine triphosphate synthase[1]
ln Vitro 3-Deazauridine (DAUR) has superior anti-tumor properties when applied to L1210 leukemia cells [1].
ln Vivo 3-Deazauridine (DAUR) (250 mg/kg/day; intraperitoneally; days 1–9) inhibits L1210 leukemia cells in mice with modest efficacy [1]. 3-Deazauridine (intraperitoneal injection; 5 doses): In beagle dogs and rhesus monkeys, the lethal doses are 250 mg/kg/day and 417 mg/kg/day, respectively; the lowest toxic doses are 62.5 mg/kg/day and 104 mg/kg/day, while the non-toxic doses are 31.25 mg/kg/day and 52 mg/kg/day, respectively[1].
References

[1]. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response. Invest New Drugs. 1986;4(1):67-84.

Additional Infomation 3-Deazauridine is a N-glycosyl compound.
3-Deazauridine is a synthetic analogue of nucleoside uridine lacking a ring nitrogen in the 3-position. 3-deazauridine inhibits cytidine synthase, thereby reducing intracellular levels of cytidine and deoxycytidine and disrupting DNA and RNA synthesis. This agent may trigger apoptosis and enhance differentiation of neoplastic cells.(NCI04)
4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent.

Solubility Data


Solubility (In Vitro) DMSO : 100 mg/mL (411.17 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2 mg/mL (8.22 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2 mg/mL (8.22 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.1117 mL 20.5584 mL 41.1167 mL
5 mM 0.8223 mL 4.1117 mL 8.2233 mL
10 mM 0.4112 mL 2.0558 mL 4.1117 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.